Abstract:Mouse zygotes undergo multiple rounds of cell division, resulting in the formation of preimplantation blastocysts comprising three lineages: trophectoderm (TE), epiblast (EPI), and primitive endoderm (PrE). Cell fate determination plays a crucial role in establishing a healthy pregnancy. The initial separation of lineages gives rise to TE and inner cell mass (ICM), from which trophoblast stem cells (TSC) and embryonic stem cells (ESC) can be derived in vitro. Studying lineage differentiation is greatly facilitated by the clear functional distinction between TSC and ESC. However, transitioning between these two types of cells naturally poses challenges. In this study, we demonstrate that inhibiting LATS kinase promotes the conversion of ICM to TE and also effectively reprograms ESC into stable, self-renewing TS-like cells (TSLC). Compared to TSC, TSLC exhibits similar molecular properties, including the high expression of marker genes such as Cdx2, Eomes, and Tfap2c, as well as hypomethylation of their promoters. Importantly, TSLC not only displays the ability to differentiate into mature trophoblast cells in vitro but also participates in placenta formation in vivo. These findings highlight the efficient reprogramming of ESCs into TSLCs using a small molecular inducer, which provides a new reference for understanding the regulatory network between ESCs and TSCs.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to promote the efficient reprogramming of mouse embryonic stem cells (ESC) into trophoblast stem - like cells (TSLC) by inhibiting LATS kinase. Specifically, the researchers focused on how to influence cell fate determination, especially the transition from the inner cell mass (ICM) to the trophectoderm (TE), by regulating LATS kinase, a key molecule in the HIPPO signaling pathway, during early embryonic development. This process is of great significance for understanding the early stages of embryonic development and the differentiation mechanisms of different cell lineages. ### Research Background and Problems 1. **Cell Fate Determination in Early Embryonic Development** - After multiple cell divisions, the mouse fertilized egg forms a blastocyst, which contains three main lineages: trophectoderm (TE), epiblast (EPI), and primitive endoderm (PrE). - Cell fate determination plays a crucial role in early embryonic development, especially in embryo implantation and pregnancy maintenance. 2. **The Role of the HIPPO Signaling Pathway** - The HIPPO signaling pathway plays an important role in cell fate determination, especially at the 8 - cell stage when inner and outer cells begin to show different changes. - LATS kinase plays a key role in this process. It regulates the nuclear localization of YAP protein by phosphorylation, thereby affecting the differentiation of TE and ICM. 3. **Differences between ESC and TSC** - Embryonic stem cells (ESC) and trophoblast stem cells (TSC) have different lineage characteristics and functional boundaries, and it is difficult to achieve the conversion between them in the natural state. - The goal of this study is to promote the transformation from ESC to TSLC by inhibiting LATS kinase, so as to better understand the regulatory network between these two cell types. ### Main Research Contents - **The Influence of LATS Kinase Inhibition on TSC** - The researchers used the small - molecule compound LATS - IN - 1 to inhibit LATS kinase and observed its influence on YAP nuclear localization and CDX2 expression in TSC. - The results showed that the inhibition of LATS kinase led to an increase in the accumulation of YAP in the nucleus and significantly up - regulated the expression of TSC marker genes (such as Cdx2, Elf5, Eomes, and Tfap2c), while down - regulating the expression of differentiation genes (such as Gcm1, Ctsq, and Prl3d1). - **The Influence of LATS Kinase Inhibition on Embryonic Differentiation** - The researchers further explored the influence of LATS kinase inhibition on embryonic lineage differentiation. They found that at the 8 - cell stage, the expression of CDX2 in embryos treated with LATS - IN - 1 increased significantly, and the number of CDX2 - positive cells increased. - As the embryos developed to the 16 - cell and 32 - cell stages, CDX2 was also expressed in the internal cells of embryos treated with LATS - IN - 1, while the expression of OCT4 decreased significantly. - When reaching the blastocyst stage (64 - cell), almost all cells in embryos treated with LATS - IN - 1 expressed CDX2, while the expression of OCT4 almost disappeared. ### Conclusion By inhibiting LATS kinase, the researchers successfully promoted the transformation from ESC to TSLC. These TSLC not only exhibited molecular characteristics similar to TSC, but also could differentiate into mature trophoblast cells in vitro and participate in placental formation in vivo. This finding provides a new reference for understanding the regulatory network between ESC and TSC.

Efficient Reprogramming of Mouse Embryonic Stem Cells into Trophoblast Stem-like Cells via Lats Kinase Inhibition

Naive Human Embryonic Stem Cells Can Give Rise to Cells with a Trophoblast-like Transcriptome and Methylome

Conversion of Mouse Epiblast Stem Cells to an Earlier Pluripotency State by Small Molecules*

Protocol to generate induced trophoblast stem cells from embryonic stem cells in mice.

Reprogramming of Trophoblast Stem Cells into Pluripotent Stem Cells by Oct4

Direct reprogramming to multipotent trophoblast stem cells, and is pluripotency needed for regenerative medicine either?

Generation of Rat and Human Induced Pluripotent Stem Cells by Combining Genetic Reprogramming and Chemical Inhibitors

Trophoblast Stem Cells1

Brief Report: Combined Chemical Treatment Enables Oct4-Induced Reprogramming from Mouse Embryonic Fibroblasts

Transcription factor-based transdifferentiation of human embryonic to trophoblast stem cells

Bilineage embryo-like structure from EPS cells can produce live mice with tetraploid trophectoderm

Derivation of Haploid Trophoblast Stem Cells Via Conversion in Vitro

Highly efficient generation of self-renewing trophoblast from human pluripotent stem cells

Reprogramming roadmap reveals route to human induced trophoblast stem cells

Inhibition of HDAC activity directly reprograms murine embryonic stem cells to trophoblast stem cells

Derivation of Mouse Haploid Trophoblast Stem Cells.

Generation of Elf5‐Cre Knockin Mouse Strain for Trophoblast‐specific Gene Manipulation

Establishment of bovine trophoblast stem-like cells from in vitro-produced blastocyst-stage embryos using two inhibitors.

ESRRB Facilitates the Conversion of Trophoblast-Like Stem Cells From Induced Pluripotent Stem Cells by Directly Regulating CDX2

Single-Stranded Dna Binding Protein Ssbp3 Induces Differentiation of Mouse Embryonic Stem Cells into Trophoblast-Like Cells

In vitro establishment of expanded-potential stem cells from mouse pre-implantation embryos or embryonic stem cells